← Back to Clinical Trials
Recruiting Phase 1 NCT04704271
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
Trial Parameters
Condition Cannabis
Sponsor Yale University
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age 55 Years
Start Date 2019-10-09
Completion 2025-12-01
Interventions
Inhaled THCPlacebo
Brief Summary
The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Eligibility Criteria
Inclusion Criteria: * At least one lifetime exposure to cannabis * Good physical and mental health Exclusion Criteria: * Cannabis naïve individuals * Major current or recent stressors